ELTP Insider Transactions
525 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ELTP insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|
| Plassche Douglas | EVP Operations | 2025-10-02 | Sale | 800,000.0 | $0.62 |
|---|
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | 2025-08-22 | Sale | 500,000.0 | $0.52 |
|---|
| Kirkov Kirko | Chief Commercial Officer | 2025-07-10 | Purchase | 16,366.0 | $0.59 |
|---|
| Plassche Douglas | EVP Operations | 2025-07-08 | Sale | 200,000.0 | $0.58 |
|---|
| Plassche Douglas | SVP of Operations | 2024-10-24 | Sale | 333,932.0 | $0.51 |
|---|
| Plassche Douglas | SVP of Operations | 2024-10-23 | Sale | 800,000.0 | $0.49 |
|---|
| TREPPEL JERRY | Other | 2016-03-18 | Sale | 258,090.0 | $0.34 |
|---|
| TREPPEL JERRY | Other | 2016-03-17 | Sale | 312,430.0 | $0.35 |
|---|
| TREPPEL JERRY | Other | 2016-02-24 | Sale | 100,456.0 | $0.31 |
|---|
| TREPPEL JERRY | Other | 2016-02-22 | Sale | 100,000.0 | $0.32 |
|---|
| TREPPEL JERRY | Other | 2016-02-17 | Sale | 50,000.0 | $0.31 |
|---|
| TREPPEL JERRY | Other | 2016-02-05 | Sale | 24,400.0 | $0.33 |
|---|
| TREPPEL JERRY | Other | 2016-02-04 | Sale | 349,660.0 | $0.32 |
|---|
| TREPPEL JERRY | Other | 2016-02-03 | Sale | 45,518.0 | $0.33 |
|---|
| TREPPEL JERRY | Other | 2016-02-02 | Sale | 13,000.0 | $0.33 |
|---|
| TREPPEL JERRY | Other | 2016-02-01 | Sale | 312,300.0 | $0.34 |
|---|
| TREPPEL JERRY | Other | 2016-01-29 | Sale | 115,000.0 | $0.35 |
|---|
| TREPPEL JERRY | Chairman of Board | 2015-11-18 | Sale | 25,000.0 | $0.31 |
|---|
| TREPPEL JERRY | Chairman of Board | 2015-11-17 | Sale | 25,000.0 | $0.3 |
|---|
| TREPPEL JERRY | Chairman of Board | 2015-11-16 | Sale | 50,000.0 | $0.3 |
|---|
| TREPPEL JERRY | Chairman of Board | 2015-11-13 | Sale | 50,000.0 | $0.3 |
|---|
| Plassche Douglas | Executive VP of Operations | 2015-04-27 | Sale | 85,530.0 | $0.24 |
|---|
| Hakim Nasrat A | CEO & President | 2014-09-26 | Purchase | 265,500.0 | $0.31 |
|---|
| Hakim Nasrat A | CEO & President | 2014-09-25 | Purchase | 434,500.0 | $0.31 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-05-09 | Sale | 329,437.0 | $0.38 |
|---|
| NARINE JEENARINE | Director | 2014-04-02 | Sale | 147,667.0 | $0.41 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-04-02 | Sale | 147,664.0 | $0.41 |
|---|
| NARINE JEENARINE | Director | 2014-04-01 | Sale | 157,012.0 | $0.41 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-03-27 | Sale | 190,172.0 | $0.43 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-03-11 | Sale | 239,367.0 | $0.6 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2014-03-11 | Sale | 239,367.0 | $0.6 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2014-03-11 | Sale | 239,367.0 | $0.6 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2014-03-11 | Sale | 239,367.0 | $0.6 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-03-07 | Sale | 1,051,450.0 | $0.68 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2014-03-07 | Sale | 1,051,450.0 | $0.68 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2014-03-07 | Sale | 1,051,450.0 | $0.68 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2014-03-07 | Sale | 1,051,450.0 | $0.68 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-03-06 | Sale | 773,050.0 | $0.9 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2014-03-06 | Sale | 773,050.0 | $0.9 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2014-03-06 | Sale | 773,050.0 | $0.9 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2014-03-06 | Sale | 773,050.0 | $0.9 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2014-01-13 | Sale | 805,583.0 | $0.18 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2014-01-13 | Sale | 805,583.0 | $0.18 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2014-01-13 | Sale | 805,583.0 | $0.18 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2014-01-13 | Sale | 805,538.0 | $0.18 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-12-05 | Sale | 275,000.0 | $0.13 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-12-05 | Sale | 275,000.0 | $0.13 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-12-05 | Sale | 275,000.0 | $0.13 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-12-05 | Sale | 275,000.0 | $0.13 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-12-02 | Sale | 100,000.0 | $0.13 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-12-02 | Sale | 100,000.0 | $0.13 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-12-02 | Sale | 100,000.0 | $0.13 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-27 | Sale | 25,000.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-27 | Sale | 25,000.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-27 | Sale | 25,000.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-27 | Sale | 25,000.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-26 | Sale | 23,626.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-26 | Sale | 23,626.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-26 | Sale | 23,626.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-26 | Sale | 23,626.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-26 | Sale | 357,000.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-26 | Sale | 357,000.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-26 | Sale | 357,000.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-26 | Sale | 357,000.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-19 | Sale | 21,000.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-19 | Sale | 21,000.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-19 | Sale | 21,000.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-19 | Sale | 21,000.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-18 | Sale | 1,170,000.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-18 | Sale | 1,170,000.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-18 | Sale | 1,170,000.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-18 | Sale | 1,170,000.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-15 | Sale | 253,050.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-15 | Sale | 253,050.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-15 | Sale | 253,050.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-15 | Sale | 253,050.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-15 | Sale | 253,050.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-15 | Sale | 253,050.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-15 | Sale | 318,050.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-15 | Sale | 318,050.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-15 | Sale | 318,050.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-15 | Sale | 318,050.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-14 | Sale | 465,090.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-14 | Sale | 465,090.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-14 | Sale | 465,090.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-14 | Sale | 465,090.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-11 | Sale | 39,000.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-11 | Sale | 39,000.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-11 | Sale | 39,000.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-11 | Sale | 39,000.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-11-06 | Sale | 122,200.0 | $0.12 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-11-06 | Sale | 122,200.0 | $0.12 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-11-06 | Sale | 122,200.0 | $0.12 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-11-06 | Sale | 122,200.0 | $0.12 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-10-29 | Sale | 102,520.0 | $0.01 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-10-29 | Sale | 139,800.0 | $0.13 |
|---|
| EPIC PHARMA LLC | TenPercentOwner | 2013-10-29 | Sale | 466,000.0 | $0.13 |
|---|
| EPIC INVESTMENTS, LLC | TenPercentOwner | 2013-10-29 | Sale | 466,000.0 | $0.13 |
|---|
| NARINE JEENARINE | Director,TenPercentOwner | 2013-10-28 | Sale | 102,300.0 | $0.13 |
|---|
| NIGALAYE ASHOK G | Chief Scientific Officer | 2013-10-28 | Sale | 139,500.0 | $0.13 |
|---|